Skip to main content
Premium Trial:

Request an Annual Quote

MDS Expects Double-Digit Revenue Growth in 2008

NEW YORK (GenomeWeb News) – MDS today announced that it expects to report 2008 revenue growth of between 12 percent and 16 percent.
 
The Toronto-based firm said its revenues for full-year 2008 should be between $1.35 billion and $1.4 billion, up from $1.2 billion in 2007.
 
MDS also said it expects to report adjusted EBITDA in the range of $175 million to $185 million and adjusted earnings per share of $.37 to $.43, compared with adjusted EBITDA of $145 million, or $.34 per share, in 2007.
 
MDS provided the guidance at its annual investor day in New York.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.